Martin Shkreli Removed As CEO From Another Drug Company

03:50

December 22, 2015

Martin Shkreli (center), then-CEO of Turing Pharmaceuticals, is brought out of 26 Federal Plaza by law enforcement officials after being arrested for securities fraud on December 17 in New York City. (Andrew Burton/Getty Images)

Martin Shkreli is back in the news today, as he has been removed as CEO from his second pharmaceutical company, California biotech firm KaloBios Pharmaceuticals.

Schkreli came under criticism this fall for dramatically hiking the price of a life-saving drug one of his companies, Turing Pharmaceuticals, acquired. The former drug company executive was also arrested last week for securities fraud, related to a hedge fund he ran years ago. Shkreli was removed the day after his arrest as CEO of Turing.

Jason Bellini of the Wall Street Journal joins Here & Now's Jeremy Hobson to discuss the latest news.

Guest

Jason Bellini, senior producer at The Wall Street Journal. He tweets @jasonbellini.

This segment aired on December 22, 2015.